| Session |
Date |
|---|---|
| A Year in the Life of a CHCO BMT Fellow | 06/11/2024 - 8:45am to 9:30am MDT |
| BMT Quality Program Meeting: Clinical Annual Report | 06/18/2024 - 8:45am to 9:30am MDT |
| CD19 CAR-T Cell Therapy in Autoimmune Disease | 06/25/2024 - 8:45am to 9:30am MDT |
| FACT Readiness | 07/02/2024 - 8:45am to 9:30am MDT |
| Updating Our Protocol for Plerixafor Use in PBSC | 07/09/2024 - 8:45am to 9:30am MDT |
| PBTC-059: HER2-Specific Chimeric Antigen Receptor (CAR) T Cells for Children with Ependymoma | 07/16/2024 - 8:45am to 9:30am MDT |
| Early Palliative Integration for Stem Cell Transplant Patients | 07/23/2024 - 8:45am to 9:30am MDT |
| Precision Medicine Expansion: Model-Based Dosing of Fludarabine in Hematopoietic Cell Transplantation | 07/30/2024 - 8:45am to 9:30am MDT |
| Vedolizumab In GI GVHD Prevention | 08/06/2024 - 8:45am to 9:30am MDT |
| Post-HSCT Maintenance Therapy for Pediatric Leukemia | 08/13/2024 - 8:45am to 9:30am MDT |

Facebook
X
LinkedIn
Forward